Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. ABSI
ABSI logo

ABSI Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Absci Corp (ABSI) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
3.950
1 Day change
10.34%
52 Week Range
5.230
Analysis Updated At
2026/04/16
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Absci Corp (ABSI) is not a strong buy at the moment for a beginner investor with a long-term focus. While the stock has shown slight positive price movement and technical indicators suggest a neutral to slightly bullish trend, the lack of significant positive catalysts, weak financial performance, and hedge fund selling pressure make it prudent to hold off on investing right now.

Technical Analysis

The MACD histogram is positive and expanding, indicating a bullish momentum. RSI is in the neutral zone at 74.745, and moving averages are converging, showing no strong directional trend. The stock is trading near its resistance level (R1: 3.283), which may limit further upside in the short term.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
5
Buy
12

Positive Catalysts

  • The MACD histogram is expanding positively, suggesting bullish momentum. Additionally, the stock has an 80% chance of increasing by 0.49% in the next day and 16.48% in the next week.

Neutral/Negative Catalysts

  • Hedge funds are aggressively selling, with a 1029.38% increase in selling over the last quarter. Financial performance is weak, with declining revenue (-2.26% YoY) and EPS (-20% YoY). Analyst sentiment is neutral, with Morgan Stanley lowering its price target slightly.

Financial Performance

In Q4 2025, revenue dropped by 2.26% YoY to $650,000. Net income improved slightly but remains negative at -$29.56 million. EPS dropped by 20% YoY to -0.2. Gross margin remained flat at 100%. Overall, the financials indicate weak growth trends.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Morgan Stanley recently lowered its price target to $4.20 from $4.32, maintaining an Equal Weight rating. This reflects a neutral stance on the stock, with no significant bullish sentiment from analysts.

Wall Street analysts forecast ABSI stock price to rise
7 Analyst Rating
Wall Street analysts forecast ABSI stock price to rise
6 Buy
1 Hold
0 Sell
Strong Buy
Current: 3.580
sliders
Low
4.32
Averages
7.66
High
10
Current: 3.580
sliders
Low
4.32
Averages
7.66
High
10
Morgan Stanley
Equal Weight
downgrade
AI Analysis
2026-03-25
Reason
Morgan Stanley
Price Target
AI Analysis
2026-03-25
downgrade
Equal Weight
Reason
Morgan Stanley lowered the firm's price target on Absci to $4.20 from $4.32 and keeps an Equal Weight rating on the shares after the company reported Q4 earnings and updates. The firm updated its model for the quarter and full year and adjusted its revenue estimates for ABS-201 slightly, the analyst noted.
Morgan Stanley
Overweight -> Equal Weight
downgrade
2026-01-08
Reason
Morgan Stanley
Price Target
2026-01-08
downgrade
Overweight -> Equal Weight
Reason
Morgan Stanley downgraded Absci to Equal Weight from Overweight with a price target of $4.32, down from $5.80. The latest company and pipeline disclosures have meaningfully increased the risk profile and reduced the visibility of near-term, value-accretive execution, contends the analyst, who is updating the firm's valuation and risk framework and, in doing so, lowering its price target and rating.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for ABSI
Unlock Now

People Also Watch